The prefrontal cortex (PFC) is enriched in several serotonin receptors, including 5-HT 1A -R, 5-HT 2A -R, and 5-HT 3 -R. These receptors modulate PFC activity due to their expression in large neuronal populations (5-HT 1A -R, 5-HT 2A -R) or in selected GABAergic populations (5-HT 3 -R). They are also relevant for antidepressant and antipsychotic drug action. Less is known about the localization of 5-HT 2C -R, for which atypical antipsychotics show high affinity. Here, we report on the cellular distribution of 5-HT 2C -R in rat PFC and striatum, using double in situ hybridization histochemistry. In PFC, 5-HT 2C -R are expressed in pyramidal (VGLUT1-positive) and GABAergic (GAD-positive) neurons, including parvalbumin-positive neurons. There is a marked dorsoventral gradient in the proportion of VGLUT1-positive cells expressing 5-HT 2C -R (9% in the cingulate cortex, 61% in the tenia tecta and 66% in the piriform cortex), less marked for GABAergic neurons (13-27%). There is also a laminar gradient, with more cells expressing 5-HT 2C -R in deep (V-VI) than in intermediate (II-III) layers. In common with 5-HT 3 -R, layer I GABAergic cells express 5-HT 2C -R. The proportion of 5-HT 2C -R-expressing striatal neurons was 23% (dorsolateral caudate-putamen), 37% (ventromedial caudate-putamen), 53% (nucleus accumbens-core), and 49% (nucleus accumbens-shell). These results help to better understand the serotonergic modulation of PFC-based networks, including basal ganglia circuits, and atypical antipsychotic drug action.
Introduction
The prefrontal cortex (PFC) is deeply involved in higher brain functions, altered in psychiatric conditions. The PFC exerts a top-down control of most cortical and subcortical areas through descending pathways (Groenewegen and Uylings 2000; Fuster 2001; Miller and Cohen 2001) . In turn, the PFC is densely innervated by serotonergic axon terminals and is enriched in several serotonin receptors, mainly 5-HT 1A -R and 5-HT 2A -R (Pazos and Palacios 1985; Pompeiano et al. 1992 Pompeiano et al. , 1994 Jakab and GoldmanRakic 2000) . These receptors are present in a relatively high proportion of pyramidal neurons and GABAergic interneurons Mengod 2007, 2008) and play a crucial role in modulating pyramidal neuron activity and cortical networks (Araneda and Andrade 1991; Zhou and Hablitz 1999; Férézou et al. 2002; Puig et al. 2003 Puig et al. , 2005 Celada, Puig et al. 2013) . Second-generation (atypical) antipsychotic drugs show high affinity for 5-HT 2A -R (Bymaster et al. 1996; Arnt and Skarsfeldt 1998; Meltzer 1999 ) and behave as direct or indirect agonists of 5-HT 1A -R (Díaz-Mataix et al. 2005; Newman-Tancredi 2010; Celada, Bortolozzi et al. 2013 ). On the other hand, 5-HT 3 -R are present in a subpopulation of GABAergic interneurons not expressing parvalbumin (PV) or somatostatin and display strong actions on neuronal activity due to their ion channel structure (Morales et al. 1996; Puig et al. 2004; Lee et al. 2010) , 5-HT 3 -R blockade may improve cognitive function (du Jardin et al. 2014; Wallace et al. 2014) and is involved in the therapeutic properties of the new antidepressant drug vortioxetine (Sanchez et al. 2015) .
Much less is known on the cellular expression and laminar distribution of other 5-HT-R, such as 5-HT 2C -R, which shows a moderate expression in PFC (Pompeiano et al. 1994 ). The 5-HT 2C -R is a G-protein-coupled receptor that activates the phospholipase C signaling pathway. It is the only 5-HT-R that undergoes A-to-I type RNA editing, which dynamically regulates its constitutive activity (Berg et al. 2008; Werry et al. 2008; Aloyo et al. 2009; O'Neil and Emeson 2012) .
Classically, the 5-HT 2C -R has been related to obesity, since 5-HT 2C -R knockout mice are obese (Tecott et al. 1995) and 5-HT 2C -R agonists decrease appetite in obese patients (Sargent et al. 1997) . Consequently, the weight gain associated with atypical antipsychotic drugs has been attributed to blockade of 5-HT 2C -R, for which they show high affinity (Bymaster et al. 1996; Arnt and Skarsfeldt 1998) , acting as inverse agonists (Meltzer 2012) . However, other receptors have also been implicated, such as the H1-R (Kim et al. 2007 ).
In addition to its involvement in weight control (likely through blockade of hypothalamic 5-HT 2C -R [Hsu et al. 2010] ), the presence of 5-HT 2C -R in PFC and anatomically related brain areas suggests that it may participate in cognitive and affective functions (Heisler et al. 2007; Boulougouris and Robbins 2010; Pennanen et al. 2013 ). In addition, midbrain 5-HT 2C -R tonically inhibit the activity of the ascending dopaminergic pathways (Gobert et al. 2000; Di Matteo et al. 2002; De Deurwaerdère et al. 2004; Di Giovanni et al. 2006) . They are also present in raphe GABA neurons, where they may exert a negative feedback control of serotonergic activity (Serrats et al. 2005) . Hence, 5-HT 2C -R blockade may have a pro-cognitive effect by locally modulating PFC networks as well as by enhancing cortical DA function. Moreover, 5-HT 2C -R blockade may have a therapeutic action in affective disorders, since it augments the citalopram-evoked serotonin (5-HT) output in the hippocampus and PFC (Cremers et al. 2004 (Cremers et al. , 2007 . Likewise, the antidepressant drug agomelatine is a mixed melatonergic MT1/MT2-R agonist and 5-HT 2C -R antagonist (Racagni et al. 2011; Srinivasan et al. 2012) . The latter activity is involved in the agomelatine-induced increase in dopamine and noradrenaline in PFC-but not in dorsal or ventral striatum (Millan et al. 2003) . Furthermore, 5-HT 2C -R agonists have been suggested as potential treatments for drug dependence (Devroye et al. 2013) .
The brain networks involved in the above cognitive and affective actions are poorly know, partly due to a limited knowledge of the cellular and laminar expression of 5-HT 2C -R in PFC. In the present study, we examined the expression of 5-HT 2C -R mRNA in pyramidal neurons (VGLUT1-positive) and GABAergic interneurons (GAD-positive) of rat PFC, as well as its laminar distribution using double in situ hybridization histochemistry. Likewise, given the major role played by PV-positive GABA interneurons in cognitive control and in schizophrenia symptoms (Gonzalez-Burgos and Lewis 2012; Lewis et al. 2012; Sohal 2012) , we also examined the expression of 5-HT 2C -R mRNA in this particular subtype of GABA interneurons. In order to compare the expression of 5-HT 2C -R mRNA in PFC with that in an area with a high receptor density, we examined the cellular expression of 5-HT 2C -R mRNA in GABAergic neurons of the dorsal (caudateputamen, CPu) and ventral (nucleus accumbens, Acb) striatum.
Experimental Procedures

Tissue Preparation
Male albino Wistar rats weighing 250-300 g were used (Iffa Credo, Lyon, France). Animals were kept in a controlled environment (12 h light-dark cycle and 22 ± 2°C room temperature) with food and water provided ad libitum. Animal care followed the European Union regulations (directive 2010/63 of 22 September 2010) and was approved by the Institutional Animal Care and Use Committee. Rats were killed by decapitation and the brains rapidly removed, frozen on dry ice, and stored at −20°C. Tissue sections, 14-µm thick, were cut using a microtome-cryostat (HM500 OM; Microm, Walldorf, Germany), thaw-mounted onto APTS (3-aminopropyltriethoxysilane; Sigma, St Louis, MO) coated slides and kept at −20°C until use.
Hybridization Probes
The oligodeoxyribonucleotide probes used were as follows. For 5-HT 2C receptor mRNA, two oligonucleotides were simultaneously used, complementary to bases 1667-1714 and 1196-1236 (GenBank accession number NM_012765). The probes were synthesized on a 380 Applied Biosystem DNA synthesizer (Foster City Biosystem, Foster City, CA, USA) and purified on a 20% polyacrylamide/8 M urea preparative sequencing gel. Glutamatergic cells were identified by the presence of the vesicular glutamate transporter 1 (VGLUT1) mRNA, with two oligonucleotides complementary to bases 127-172 and 1756-1800 (GenBank accession number U07609). GABAergic cells were identified by the presence of the GABA synthesizing enzyme, glutamic acid decarboxylase (GAD). One oligonucleotide for the GAD 67 isoform was used, complementary to bases 1600-1653 (GeneBank accession number NM_017007). PV-positive cells were detected by one oligonucleotide probe complementary to bases 329-373 (GenBank accession number NM_002854). They were synthesized and HPLC purified by Isogen Bioscience BV (De Meern, The Netherlands).
Each 5-HT 2C receptor oligonucleotide was individually labeled (2 pmol) at its 3′-end with [ 33 P]-dATP (>2500 Ci/mmol; PerkinElmer NEN Radiochemicals, Boston, MA, USA) using terminal deoxynucleotidyltransferase (TdT, Calbiochem, Darmstadt, Germany). VGLUT1, GAD, and PV oligonucleotides (100 pmol) were nonradioactively labeled with recombinant TdT (Roche Diagnostics GmbH, Penzberg, Germany) and digoxigenin (DIG)-11-dUTP (Boehringer Mannheim, Mannheim, Germany) according to a previously described procedure (Schmitz et al. 1991) . Labeled probes were purified using ProbeQuant G-50 Micro Columns (GE Healthcare, Buckinghamshire, UK).
In Situ Hybridization Histochemistry Procedure
The protocols for single-and double-label in situ hybridization histochemistry were based on previously described procedures (Tomiyama et al. 1997; Landry et al. 2000) and have been reported in detail (Serrats et al. 2003) . Frozen tissue sections were first brought to room temperature, fixed for 20 min at 4°C in 4% paraformaldehyde in phosphate-buffered saline (1× PBS: 8 mM Na 2-HPO 4 , 1.4 mM KH 2 PO 4 , 136 mM NaCl, 2.6 mM KCl), washed for 5 min in 3× PBS at room temperature, twice for 5 min each in 1× PBS, and incubated for 2 min at 21°C in a solution of predigested pronase (Calbiochem, San Diego, CA, USA) at a final concentration of 24 U/mL in 50 mM Tris-HCl pH 7.5, 5 mM EDTA. The enzymatic activity was stopped by immersion for 30 s in 2 mg/mL glycine in 1× PBS. Tissues were finally rinsed in 1× PBS and dehydrated through a graded series of ethanol. For hybridization, the radioactively labeled and the nonradioactively labeled probes were diluted in a solution containing 50% formamide, 4x SSC (1× SSC: 150 mM NaCl, 15 mM sodium citrate), 1× Denhardt's solution (0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin), 10% dextran sulfate, 1% sarkosyl, 20 mM phosphate buffer pH 7.0, 250 µg/mL yeast tRNA, and 500 µg/mL salmon sperm DNA. The final concentrations of radioactive and Dig-labeled probes in the hybridization buffer were in the same range (∼1.5 nM). Tissue sections were covered with hybridization solution containing the labeled probe/s, overlaid with Nescofilm coverslips (Bando Chemical Ind, Kobe, Japan) and incubated overnight at 42°C in humid boxes. Sections were then washed four times (45 min each) in 0.6 M NaCl, 10 mM Tris-HCl pH 7.5 at 60°C, and once in the same buffer at room temperature for 30 min.
Development of Radioactive and Nonradioactive Hybridization Signal
Hybridized sections were treated as described by Landry et al. (2000) . Briefly, after washing, the slides were immersed for 30 min in a buffer containing 0.1 M Tris-HCl pH 7.5, 1 M NaCl, 2 mM MgCl 2 , and 0.5% bovine serum albumin (Sigma, Steinheim, Germany) and incubated overnight at 4°C in the same solution with alkaline-phosphate-conjugated anti-digoxigenin-F(ab) fragments (1:5000; Roche Diagnostics GmbH, Mannheim, Germany). Afterwards, they were washed three times (10 min each) in the same buffer (without antibody), and twice in an alkaline buffer containing 0.1 M Tris-HCl pH 9.5, 0.1 M NaCl, and 5 mM MgCl 2 . Alkaline phosphatase activity was developed by incubating the sections with 3.3 mg nitroblue tetrazolium and 1.65 mg bromochloroindolyl phosphate (Roche Diagnostics GmbH) diluted in 10 mL of alkaline buffer. The enzymatic reaction was blocked by extensive rinsing in the alkaline buffer containing 1 mM EDTA. The sections were then briefly dipped in 70 and 100% ethanol, air-dried, and dipped into Ilford K5 nuclear emulsion (Ilford, Mobberly, Chesire, UK) diluted 1:1 with distilled water. They were exposed in the dark at 4°C for 6 weeks, and finally developed in Kodak D19 (Kodak, Rochester, NY, USA) for 5 min, and fixed in Ilford Hypam fixer (Ilford). For film autoradiography, some hybridized sections were exposed to Biomax-MR (Kodak) films for 2-4 weeks at −70°C with intensifying screens.
Specificity of the Probes
The specificity of the hybridization signals has been previously established and published (Pompeiano et al. 1992; Serrats et al. 2003) . These controls included the following procedures. (1) The thermal stability of the hybrids was examined for every probe by washing at increasing temperatures: a sharp decrease in the hybridization signal was observed at a temperature consistent with the Tm of the hybrids. (2) For a given oligonucleotide probe, the hybridization signal was completely blocked by competition of the labeled probe in the presence of 50-fold excess of the same unlabeled oligonucleotide. (3) Since we synthesized more than one probe for each mRNA analyzed, the hybridization signal obtained with each oligonucleotide for the same mRNA was identical at both regional and cellular levels when used independently. (4) To assure the specificity of the nonradioactive hybridization signal, we compared the results obtained with the same probe radioactively labeled.
Analysis of the Results
Tissue sections were examined and cells quantified with an Olympus BX51 Stereo Microscope (Olympus, Tokyo, Japan) equipped with an Olympus Microscope Digital Camera DP71 and Visiopharm Integrator System (VIS) (Visiopharm Software, Hørsholm, Denmark). Co-expression of VGLUT1, GAD, or PV mRNAs (all Dig-labeled) with 5-HT 2C -R mRNA (radioactively labeled) was estimated by counting the number of Dig-labeled cellular profiles which also expressed 5-HT 2C -R mRNA, using a systematic random sampling tool. The number of Dig-labeled cells was considered as 100% (either VGLUT1, GAD, or PV). Only cellular profiles showing 3-fold density of silver grains higher than background were considered to be double-labeled. For cortical counting estimation, regions of interest (ROIs) were drawn in each layer and PFC subdivision with the aid of VIS software using Swanson brain map's layers as reference (Swanson 2004) . Moreover, cytoarchitectonic criteria of VGLUT1-positive sections, including differential shape and size of cells in cortical layers II-VI, were used as an internal control. For delineation of ROIs in the striatum, the Paxinos and Watson (2005) brain map was used as reference. Dorsolateral and ventromedial CPu subdivisions were chosen using connectivity criteria (Voorn et al. 2004) . Nucleus accumbens (Acb) core boundaries were delineated using the inferior tip of the lateral ventricle and the anterior commissure as reference. Acb shell boundaries were estimated using ventral pallidum as ventral reference and lateral septum as medial reference. Data are means ± SEM of three rats (triplicate sections per rat). The figures were prepared for publication using Adobe Photoshop software (Adobe Software, Mountain View, CA, USA). Analysis of variance (ANOVA) and post hoc Tukey's (for one-way ANOVA) or Bonferroni (for two-way ANOVA) tests were performed using GraphPad Prism software (GraphPad Software, San Diego, CA, USA). P < 0.05 was considered statistically significant. Figure 1 shows the expression pattern of 5-HT 2C -R mRNA in several subcortical structures along the rostrocaudal axis of rat brain. The most prominent expression of this receptor was found in choroid plexuses of third and lateral ventricles (B1) and CA1/ventral subiculum (VS) subdivisions of the ventral hippocampus (C1). A moderate-high expression was found in striatal structures such as the nucleus accumbens (Acb), the caudate-putamen (CPu), and the ventral tegmental area (VTA). Likewise, some thalamic nuclei, as well as the retrosplenial cortex (Rs), exhibited a high expression of this receptor (B1, C1).
Results
Expression of 5-HT 2C -R mRNA in PFC Subfields
In the PFC, the expression of the 5-HT 2c -R transcript showed a marked dorso-ventral gradient, with a moderate expression in dorsal compared with ventral fields. In dorsal fields, the most prominent expression was seen in deep layers (V-VI) of the three medial prefrontal cortex (mPFC) subdivisions, infralimbic (IL), prelimbic (PrL), and dorsal anterior cingulate (Cg), which exhibited the lower expression. Other cortical areas, such as the primary and secondary motor areas (M1/M2), the agranular insular cortex (AI), and the ventral/lateral orbital cortex (VO/LO), also expressed the 5-HT 2c -R transcript. PFC areas ventral to the rhinal fissure (from now on, referred to as "ventral PFC"), such as tenia tecta (TT), piriform cortex (Pir), and anterior olfactory nucleus (AON), were more enriched in 5-HT 2C -R mRNA than more dorsal areas of PFC (Figs 2 and 3) .
We examined the cellular distribution of 5-HT 2c -R mRNA in pyramidal (VGLUT1-positive) and GABAergic (GAD-positive) neurons (Fig. 4) . Both neuronal types expressed 5-HT 2c -R in all subdivisions of PFC examined, yet in a greater proportion by pyramidal cells in ventral PFC subdivisions, such as TT and Pir (see below). A moderate proportion of PV-positive cells, a subgroup of GABAergic interneurons, expressed 5-HT 2c -R.
An abundant proportion of cells in ventral and ventrolateral areas of PFC expressed 5-HT 2C -R mRNA (Fig. 5) . Figure 5A1 -A5
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shows the presence of 5-HT 2c -R mRNA in pyramidal neurons of these areas. A great number of pyramidal cells expressing 5-HT 2c -R were observed in piriform cortex and AON, whereas a more moderate number were found in AI. A large proportion of GABAergic cells of Acb at this AP level (Fig. 5B1) showed the presence of this receptor. Glutamatergic, GABAergic or PV-positive cells of orbital cortex expressed 5-HT 2c -R mRNA in a low proportion. Figure 6 shows the quantitative distribution of 5-HT 2c -R mRNA in glutamatergic, GABAergic, and PV-positive neurons of mPFC subdivisions (IL, PrL, and Cg), VO/LO, AI, TT, and Pir. Overall, 5-HT 2c -R expression was moderate in dorsal aspects of the mPFC and AI, with a similar percentage of excitatory and inhibitory neurons expressing 5-HT 2c -R. However, ventral PFC areas such as TT and Pir exhibited a much greater proportion of pyramidal neurons expressing 5-HT 2c -R (∼60%), which was three times greater than that of GABAergic interneurons expressing 5-HT 2c -R in the same areas.
One-way ANOVA showed a significant effect of the region on the proportion of VGLUT1-positive neurons expressing 5-HT 2c -R (region factor: F 6,14 = 490.7, P < 0.0001). Nine to sixteen percent of VGLUT1-positive cells expressed 5-HT 2c -R, with a dorso-ventral positive gradient, being IL the area where maximal expression was found. Almost 20% of AI glutamatergic neurons expressed the 5-HT 2c -R. The percentage of GABAergic cells expressing 5-HT 2c -R was slightly higher than that of glutamatergic cells, particularly in Cg (13.5 vs. 9.5%, respectively) and was similar in PrL and IL, exhibiting also a DV-positive gradient (region factor: F 7,16 = 14.07, P < 0.0001, one-way ANOVA). Although there were some differences in the percentage of GABAergic neurons expressing 5-HT 2c -R in the different mPFC areas, these did not reach statistical significance in most instances, except in TT and VO/LO (Fig. 6) .
Interestingly, unlike other G-protein-coupled 5-HT-R (see Discussion), a 10% of GABAergic cells in layer I expressed 5-HT 2c -R. A small proportion of PV-positive neurons expressed 5-HT 2c -R mRNA in all areas examined (see mean and deviation values in Supplementary Table S1 ). Figure 7 shows the layer distribution of 5-HT 2c -R mRNA in mPFC. About 15% of pyramidal cells in deep layers of mPFC expressed the 5-HT 2c -R transcript. As observed for all sections examined at this AP coordinate, in the mPFC layers V-VI, there was also a positive dorso-ventral gradient in the percentage of cells expressing 5-HT 2c -R in deep layers, with a higher expression in IL > PrL > Cg (Fig. 7A) . The percentage of pyramidal cells expressing 5-HT 2c -R in layers II-III was low (ca. 5% on average) and also showed a positive dorso-ventral gradient. The expression of 5-HT 2c -R was significantly lower in layers II-III compared with layers V-VI in all three mPFC subdivisions (layer factor: F 2,12 = 12.05, P < 0.005; region factor: F 1,12 = 72.56, P < 0.0001, two-way ANOVA).
The percentage of GABAergic cells expressing 5-HT 2c -R mRNA was ∼10% in layers V-VI of the IL, PrL, and Cg subdivisions and was very similar in all of them (Fig. 7B) . Interestingly, the percentage of GABAergic cells expressing 5-HT 2c -R mRNA in layers II-III exhibited a positive dorso-ventral gradient, similar to that exhibited by pyramidal (VGLUT1+) neurons in the same layers, although this difference did not reach statistical significance (layer factor: F 2,12 = 3.393, P = 0.0679; region factor: F 1,12 = 0.8417, P = 0.3770, two-way ANOVA).
The percentage of PV-positive cells expressing the 5-HT 2c -R mRNA was lower than that of all GABAergic cells in all layers and subdivisions, suggesting that the receptor is expressed in different subtypes of GABAergic interneurons. The difference was maximal in layers II-III of the IL subdivision, where <5% of PVpositive cells express 5-HT 2c -R (compared with the ∼15% of GAD-positive cells in the same location [ Fig. 7C]) . 
Comparison with Rostral PFC and Striatum
In order to compare 5-HT 2C -R PFC expression with more rostral and posterior areas also rich in 5-HT 2C -R mRNA, we examined its distribution in (1) a more rostral coordinate within the PFC (bregma + 5.1 mm; Fig. 8 ), and (2) a more caudal coordinate (bregma + 2.2 mm), a section including the CPu and the shell and core subdivisions of Acb (Fig. 9) . In rostral PFC, the expression of the 5-HT 2C -R transcript was more prominent in deep versus superficial layers of all subdivisions: primary and secondary motor areas (M1/M2), PrL, medial orbital cortex (MO), VO/LO, and dorsolateral orbital cortex (DLO) (Fig. 8A) . The proportion of pyramidal (VGLUT1-positive) and GABAergic (GAD-positive) neurons expressing 5-HT 2C -R mRNA in these areas is shown in Figure 8B . Both neuronal types expressed 5-HT 2C -R in a similar proportion (∼15% on average) in all subdivisions examined. PrL was the area with the greatest expression of 5-HT 2C -R mRNA, although the difference did not reach statistical significance in either neuronal type (region factor: (Fig. 8B1) . Considering layer subdivision, 5-HT 2C -R mRNA expression was significantly higher in layers V-VI than in layers II-III of ventrolateral aspects of orbital cortex at this AP coordinate. About 30-40% of VGLUT1-positive cells in layers V-VI contain 5-HT 2C -R mRNA, opposite to a much lower expression (∼5%) in superficial layers (II-III) (layer factor: F 1,8 = 88.31, P < 0.0001; region factor: F 1,8 = 3.814, P = 0.0866, two-way ANOVA) (Fig. 8B2) . On the other hand, the percentage of GABAergic cells expressing 5-HT 2C -R was significantly higher in deep than in superficial layers of DLO, but not in VO/LO, where all layers expressed the same proportion of this receptor (nearly 10% of GAD-positive cells) (layer factor: F 1,8 = 0.6509, P = 0.4431; region factor: F 1,8 = 3.375, P = 0.1035; interaction: F 1,8 = 6.576, P < 0.05, two-way ANOVA) (Fig. 8B3 ). Figure 8C ( panels C1-C4) shows examples of 5-HT 2C -R expression in layers V-VI of VO/LO and DLO at AP + 5.1 mm from bregma.
5-HT 2C -R mRNA is highly expressed in all striatum subdivisions (bregma + 2.2 mm); Figure 9 ). Acb core showed the highest proportion of cells expressing 5-HT 2C -R at this AP coordinate, where almost 60% of GABAergic cells express 5-HT 2C -R mRNA. In contrast, the receptor was less expressed in dlCPu cells (ca. 20%). One-way ANOVA showed a significant effect of the region on the proportion of GAD-positive neurons expressing 5-HT 2C -R (region factor: F 3,8 = 18.9, P < 0.001) (Fig. 9C) .
Discussion
The present report complements and extends previous studies of our group on the role of monoaminergic innervation in the control of PFC activity, and in particular, on the expression of monoaminergic receptors by pyramidal neurons and GABAergic interneurons. Figure 10 shows the regional distribution in the PFC of the mRNAs encoding four serotonergic receptors (5-HT 1A -R, 5-HT 2A -R, 5-HT 2C -R, and 5-HT 3 -R), dopamine D 1 -R and D 2 -R, and α 1A -, α 1B -and α 1C -adrenoceptors, as well as their proportions in pyramidal and GABAergic neurons in the different mPFC subdivisions, as observed in previous and present studies (Amargós-Bosch et al. 2004; Puig et al. 2004; Santana et al. 2004 Santana et al. , 2009 Santana et al. , 2013 . With the exception of 5-HT 3 -R, selectively expressed in GABAergic interneurons located mainly in layers I-III, the rest of monoaminergic receptors are present in both neuronal types in varying proportions, and in middle (II-III) and deep (V-VI) layers of the Cg, Prl, and IL subdivisions. Some of them are highly co-localized in mPFC Early in situ hybridization and autoradiographic studies identified the presence of 5-HT 2C -R in several brain areas, including the neocortex ( prefrontal, piriform, retrosplenial, and entorhinal cortices) and subcortical structures such as basal ganglia, amygdala, hippocampus, and monoaminergic nuclei (Pazos and Palacios 1985; Molineaux et al. 1989; Mengod et al. 1990; Pompeiano et al. 1994; Eberle-Wang et al. 1997; López-Giménez et al. 2001) . Immunohistochemical analyses found a similar regional distribution (Abramowski et al. 1995; Clemett et al. 2000) . At the cellular level, the 5-HT 2C -R has been identified in GABAergic and dopaminergic cells of the ventral tegmental area and in GABAergic cells of the dorsal raphe and PFC (Serrats et al. 2005; Boothman et al. 2006; Liu et al. 2007 ). Likewise, 5-HT 2C -R have been identified in glutamatergic cells using single-cell RT-PCR (Vysokanov et al. 1998; Feng et al. 2001; Carr et al. 2002) . subdivisions of medial PFC. Data are mean ± SEM of three rats per group. *P < 0.05 versus layer II-III, two-way ANOVA followed by the Bonferroni post hoc test.
The regional distribution of 5-HT 2c -R mRNA in PFC reported herein agrees well with early work using in situ hybridization and autoradiographic studies (Pazos and Palacios 1985; Mengod et al. 1990; Pompeiano et al. 1994) . We found that the 5-HT 2c -R mRNA is unevenly distributed in rat PFC, with a marked dorso-ventral gradient, which may follow the distribution of 5-HT itself, and suggests the involvement of 5-HT 2C -R in emotional processing. In this regard, 5-HT depletion impairs reward-associated reversal learning but not the more abstract extra-dimensional shift learning (Clarke et al. 2005 ). In the mPFC, 5-HT 2c -R mRNA is present in pyramidal neurons (VGLUT1-positive) and GABAergic interneurons (GAD-positive), with a greater abundance in deep layers of the mPFC (V-VI, mainly in the boundary between both layers) than in intermediate layers (II-III) showing also a positive dorso-ventral gradient (e.g., IL > PrL > Cg). Interestingly, the higher proportion of neurons expressing 5-HT 2c -R mRNA in layers V-VI was also found at a more rostral PFC coordinate (bregma + 5.1 mm), indicating a preferential distribution of the receptor in deep layers along the rostrocaudal axis, The receptor is also expressed in PV-positive neurons, although in a lower proportion than in the total of GABAergic neurons. Ventral prefrontal areas, such as olfactory and striatal structures (AON, Pir, and rostral Acb), express abundantly 5-HT 2C -R mRNA. To our knowledge, this is the first quantitative study of the expression of this receptor at cellular level in the mammalian cortex. These observations contribute to a better understanding of the complex actions of 5-HT on PFC neuronal activity and its control of subcortical structures via descending inputs.
GABAergic neurons were identified by the presence of GAD 67 mRNA. Given that both GAD 67 and GAD 65 isoforms are coexpressed in the majority of GABA-positive neurons in the brain (Erlander and Tobin 1991; Feldblum et al. 1993; Esclapez et al. 1994) , we used only one probe to identify this neuronal type since the high level of nonradioactive signal obtained with two digoxygenin-labeled oligonucleotides prevented the correct visualization of silver grains over GAD-positive cellular profiles.
Cortical GABAergic interneurons are classified according to several characteristics such as morphology, connectivity, electrophysiological properties, and expression profile of neuropeptides and calcium binding proteins, such as PV, calbindin, or calretinin (Ascoli et al. 2008; DeFelipe et al. 2013) . PV-positive neurons are a subpopulation of GABAergic cells comprising chandelier and large basket cells (DeFelipe 1997). These interneurons exert a tight control of the signal output from the PFC to subcortical areas since they synapse on cell bodies (basket cells) or in the initial segment of the axon of layer V pyramidal cells (chandelier cells) (DeFelipe and Farinas 1992) , where initiation of action potential occurs. Given that PV-positive neurons represent only a fraction of all GABA interneurons, the present results indicate that 5-HT 2c -R are expressed by various subtypes of GABAergic interneurons, since the 5-HT 2c -R mRNA was identified only in a small proportion of PV-positive GABAergic neurons. This view is also supported by the observation that 5-HT 2c -R mRNA is also present on layer I GABAergic interneurons which are not PV-positive. Hence, 5-HT 2c -R may indirectly modulate pyramidal neuron activity by controlling axo-somatic and axoaxonic GABAergic inputs (deep layers) as well as axo-dendritic inputs onto the tufts of apical dendrites (layer I). 5-HT 3 -R )-but not 5-H1 1A -R or 5-HT 2A -R -are also present in layer I GABAergic interneurons, indicating the existence of a complex serotonergic control of distal inputs onto apical dendrites. Interestingly, inputs onto dendritic tufts have been considered important for associative learning and are mostly of cortical origin. However, 5-HT 2C -R and 5-HT 3 -R may also modulate thalamocortical inputs, since, in addition to the well-known input onto layer IV, there is a dense thalamic input onto cortical layer I in all areas of the rodent cortex (Rubio-Garrido et al. 2009 ). Interestingly, we found a similar proportion of pyramidal and GABAergic neurons expressing 5-HT 2c -R mRNA in the various subdivision of the mPFC (9-16% for pyramidal neurons, ∼10% for GABAergic interneurons). A previous immunohistochemical study reported the presence of 5-HT 2C -R in PFC (Liu et al. 2007 ). The authors found a 50% of 5-HT 2C -R immunoreactive cells in PrL were also GAD 67 -positive. Although the data of the two studies are not directly comparable, both indicate a similar proportion of excitatory and inhibitory neurons expressing 5-HT 2C -R in PrL. This ratio is different from 5-H1 1A -R and 5-HT 2A -R, which are preferentially expressed by pyramidal neurons or from 5-HT 3 -R, which are expressed mostly by GABAergic interneurons (Morales and Bloom 1997; Puig et al. 2004 ). However, more ventral areas of the PFC, such as TT or Pir exhibited a much greater abundance of pyramidal neurons (>60%) expressing 5-HT 2C -R, together with a larger pyramidal/GABAergic proportion (∼3) than in dorsal PFC areas, such as mPFC. These different proportions indicate that 5-HT 2c -R stimulation or blockade may have entirely different effects on pyramidal neuron activity and therefore, on the function of the different PFC subdivisions.
Overall, the proportion of 5-HT 2C -R-expressing cells in medial aspects of the PFC was lower than that in the piriform cortex and tenia tecta, where more than 60% of VGLUT1-positive cells express the receptor. Likewise, the proportion of 5-HT 2C -R-expressing cells in medial PFC was also lower than in subcortical regions rich in 5-HT 2C -R, such as the Acb, where more than 50% of the neurons expressed the receptor. The presence of 5-HT 2C -R-in pyramidal and GABA neurons of the mPFC, as well as in Figure 10 . Schematic representation of the expression of 5-HT2C-R. In PFC, in basal ganglia circuits. Deep layers of the mPFC contain the pyramidal neurons projecting to midbrain (e.g., dorsal and median raphe nuclei, DR/MnR and ventral tegmental area, VTA [not shown in the figure] ) and to dorsal and ventral striatum (CPu, caudateputamen; Acb, nucleus accumbens). 5-HT 2c -R are also expressed in a high proportion of medium-size spiny GABA neurons in the striatum, as well as in substantia nigra reticulata (SNr) (Eberle-Wang et al. 1997) , which receives striatal inputs through the direct and indirect pathways (the latter via globus pallidus, ventral pallidum, and subthalamic nucleus, GP, VP, and STN, respectively). GABA cells in the SNr tonically inhibit excitatory neurons in thalamic nuclei. Several thalamic nuclei (but not the mediodorsal and centromedial nuclei-MD/CM-that project to PFC) contain a high density of cells expressing 5-HT2c-R (Clemett et al. 2000) . Thalamic inputs reach the neocortex in layers I and IV (Rubio-Garrido et al. 2007 ), except in PFC, lacking layer IV, where thalamic inputs input reach layers III, V, and VI (Kuroda et al. 1998 ). In addition, most GABA neurons in the dorsal raphe nucleus (DR) express 5-HT 2C -R (Serrats et al. 2005) , which may exert a local negative feedback mechanism on 5-HT neuronal activity.
the receptive fields of pyramidal neurons, such as CPu and Acb, suggests an important-and likely complex-role of this receptor in the processing of information along basal ganglia circuits (see scheme in Fig. 11) . Indeed, based on the present study, we cannot estimate the percentage of pyramidal neurons projecting to dorsal and ventral striatum express 5-HT 2C -R mRNA. However, these pyramidal neurons are located in layers V-VI of Cg-PrL (CPu) and PrL-IL (Acb) subdivisions, respectively, as well as in VO/LO (Gabbott et al. 2005) , where cells expressing 5-HT 2C -R are located. Therefore, 5-HT 2C -R activation may directly or indirectly (via local networks) modulate the PFC output to the striatum. Therefore, it is likely that endogenous 5-HT can modulate the processing of cognitive and affective signals along basal ganglia circuits by acting at PFC level, via the activation of 5-HT receptors located in deep layers (5-HT 1A -R, 5-HT 2A -R, and 5-HT 2C -R) ; this study) as well as by activating 5-HT 2C -R in striatal medium-size spiny GABA neurons receiving these cortical inputs. This complex interaction may also be involved in action of psychotropic drugs acting on 5-HT 2C -R. Additionally, 5-HT 2C -R in GABA cells of the midbrain raphe may exert a negative feedback regulation of serotonergic activity at somatodendritic level (Serrats et al. 2005) , which adds a further element of complexity. Hence, 5-HT 2C -R blockade by atypical antipsychotic drugs (or of certain antidepressant drugs, such as agomelatine) may affect the activity of basal ganglia circuits at various levels, effects possibly involved in the therapeutic action of these agents.
As summarized above, 5-HT 2C -R blockade has been associated with the antipsychotic-induced weight gain. However, the presence of 5-HT 2C -R in PFC suggests its involvement in the processing of cognitive and/or emotional signals. 5-HT 2C -R blockade by antipsychotic drugs in PFC may add to the effects on the control of dopaminergic neurotransmission by midbrain 5-HT 2C -R (Gobert et al. 2000; Di Matteo et al. 2002; De Deurwaerdère et al. 2004; Di Giovanni et al. 2006) , since 5-HT 2C -R stimulation in PFC facilitates drug-induced dopamine release in the nucleus accumbens (Leggio et al. 2009 ). On the other hand, the selective enrichment of 5-HT 2C -R in ventral regions may indicate its participation in emotional processing, given the role of ventral PFC regions in emotional control. Hence, alterations of the energy metabolism in the ventral cingulate have been reported in mood disorders (Seminowicz et al. 2004; Drevets et al. 2008 ) and deep brain stimulation of these ventral areas evokes immediate antidepressant effects in treatment-resistant depressed patients (Mayberg et al. 2005; Puigdemont et al. 2012) .
In summary, the present study shows a heterogeneous 5-HT 2C -R distribution in rat PFC, expressed in pyramidal neurons and GABAergic interneurons in different proportions, depending on the area examined, although lower in most instances than that present in a subcortical structure rich in 5-HT 2C -R, such as Acb. The percentage of cells expressing the receptor exhibits marked dorso-ventral and medio-lateral (in mPFC) gradients at different AP coordinates. Overall, the present results improve our knowledge of the role of serotonergic neurotransmission in the control of PFC function and help to better understand the interaction of psychoactive drugs (mainly atypical antipsychotics) with PFC networks involved in cognitive and emotional processing. 
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